Bookmark

Add to MyYahoo RSS

Hematology News

News on Hematology continually updated from thousands of sources around the net.

19 hrs ago | Hispanic Business

U.S. Food and Drug Administration Approves Gilead's Zydelig ...

Zydelig is indicated in combination with rituximab for patients with relapsed chronic lymphocytic leukemia for whom rituximab alone would be considered appropriate therapy and as monotherapy for patients with relapsed follicular B-cell non-Hodgkin lymphoma and small lymphocytic lymphoma who have received at least two prior systemic therapies.

Comment?

Related Topix: Healthcare Law, Law, Food and Drug Administration, Leukemia, Health, Lymphoma, Marketing, Medicine

Tue Jul 29, 2014

ClickOnDetroit

2 doctors bonded by cancer now give back at Children's Hospital

Dr. Jeffrey Taub understands there is life after cancer. He spent his teenage years at the Children's Hospital Michigan winning his own fight against the disease.

Comment?

Related Topix: Medicine, Oncology

MLive.com

Charley Honey: Cancer, chemo all part of spiritual journey for Sister Sue Tracy

Sister Sue Tracy chats with registered nurse Carol Yost, while her guardian-angel doll Ama looks on.

Comment?

Related Topix: Medicine, Oncology

Medical News Today

SapC-DOPS selectively targets tumor cells in models with brain...

Over half of patients being seen in the clinic for a diagnosed brain tumor have metastatic cancer , which has no treatment and detrimental outcomes in most cases.

Comment?

Related Topix: Health, Brain Cancer, Oncology, Medicine, University of Cincinnati, Biology, Science, Pancreatic Cancer

The Jersey Journal

Health notes

CarePoint Health has announced that hematology and oncology specialist, Dr. Hitendra Upadhyaya, and physician Dr. Edward Boylan have joined the network, CarePoint Health Medical Group.

Comment?

Related Topix: Oncology, Medicine, Hudson County, NJ, Bayonne, NJ, Hoboken, NJ, University of Chicago

Mon Jul 28, 2014

Lymphoma Info

FDA Expands Use of Imbruvica to Include CLL Patients with 17p Deletion

Well ahead of schedule, the US Food and Drug Administration today expanded the approved use of Imbruvica to treat patients with chronic lymphocytic leukemia who carry a deletion in chromosome 17 , associated with poor responses to standard treatment for CLL.

Comment?

Related Topix: Food and Drug Administration, Healthcare Law, Law, Leukemia, Health, Oncology, Medicine

Sun Jul 27, 2014

The News-Star

Data: Shreveport specialist collected largest individual share of La. Medicare payments in '12

Hematolgist/oncologist Manish Dhawan's Medicare payments totaled slightly more than $5 million that year, according to data the U.S. Centers for Medicare and Medicaid released earlier this year.

Comment?

Related Topix: Shreveport, LA, Oncology, Medicine, Bossier City, LA

Fri Jul 25, 2014

CFRA

Blood thinner ineffective in preventing pregnancy complications from clots: study

Pregnant women with clotting disorders are often prescribed a challenging and cringe-inducing treatment - daily doses of a blood-thinner injected into the abdomen - in a bid to prevent a miscarriage or other complications.

Comment?

Related Topix: Medicine

Medical News Today

Biosimilar Retacrit effective in chemotherapy-induced anemia

Hospira, the world's leading provider of injectable drugs and infusion technologies, announced today that the results from the ORHEO study have been published in BMC Cancer , and show that the company's European biosimilar epoetin, Retacrit was effective and well tolerated in the management of chemotherapy-induced anemia in patients with solid ... (more)

Comment?

Related Topix: Oncology, Medicine, Lymphoma, Health

Thu Jul 24, 2014

Seeking Alpha

Celgene's (CELG) CEO, Robert Hugin on Q2 2014 Results - Earnings Call Transcript

Good morning and welcome to the Celgene Second Quarter 2014 Earnings conference call.

Comment?

Related Topix: Biotech, Celgene, Medicine, Healthcare Industry, Oncology

Scientific American

Heparin Does Not Reduce Pregnancy Complications, and May Create Some

For the past 20 years pregnant women with an increased risk of developing blood clots have often been prescribed a common blood thinner to prevent serious complications from the clots, including preeclampsia , disruption of the placenta, low birth weight and loss of the fetus.

Comment?

GlobeNewswire

Connecticut Children's Medical Center Welcomes Four New Physicians

Connecticut Children's Medical Center is pleased to announce the recent appointment of four new physicians to its Divisions of Hematology and Oncology, Emergency Medicine, Sleep Medicine and General Pediatrics.

Comment?

Related Topix: Medicine, Connecticut Children's Medical Center, Hospital Administration, Healthcare Industry, Oncology, Pediatrics, College of William and Mary, University of Connecticut

PhysOrg Weblog

Metastatic brain tumor treatment could be on the horizon with use of SapC-DOPS

Over half of patients being seen in the clinic for a diagnosed brain tumor have metastatic cancer, which has no treatment and detrimental outcomes in most cases.

Comment?

Related Topix: Health, Brain Cancer, Medicine, Oncology, University of Cincinnati, Biology, Science, Breast Cancer

Wed Jul 23, 2014

Hispanic Business

Study Results from Department of Hematology Update Understanding of...

Cytogenetically, 16 patients were defined as good risk, 56 as intermediate risk, and nine as poor risk, following the , "The pre-transplant conditioning regimen consisted of high-dose busulfan, etoposide, and cytarabine , combined with priming by granulocyte colony-stimulating factor .

Comment?

Related Topix: Medicine, Leukemia, Health, Stem Cell Research, Science / Technology

Drugs.com

FDA Approves Zydelig (idelalisib) for CLL and Lymphoma

July 23, 2014 -- The U.S. Food and Drug Administration today approved Zydelig to treat patients with three types of blood cancers.

Comment?

Related Topix: Food and Drug Administration, Lymphoma, Health, Leukemia, Oncology, Medicine

Business Journal

Children's Hospital of San Antonio adding pediatric cancer expertise

The Children's Hospital of San Antonio has taken another step in its quest to develop a world-class pediatric cancer program.

Comment?

Related Topix: Pediatric Cancer, Health, Oncology, Medicine

Customer Interaction Solutions

Research and Markets: World Market for Hematology Report

Used for both critical and routine testing, hematology is a central part of IVD.

Comment?

Related Topix: Medicine, Infectious Diseases

Tue Jul 22, 2014

EurekAlert!

ASH honors Scott Armstrong, M.D., Ph.D., with 2014 William Dameshek Prize

The American Society of Hematology will present the 2014 William Dameshek Prize to Scott Armstrong, MD, PhD, of Memorial Sloan Kettering Cancer Center for his exceptional work in leukemia research and cancer stem cell biology.

Comment?

Related Topix: Medicine, Memorial SloanKettering Cancer Center, Hospital Administration, Healthcare Industry, Leukemia, Health, Cell Biology, Stem Cell Research, Science / Technology, Biology, Science, Genetics

EurekAlert!

Tomas Ganz, M.D., Ph.D., to present 2014 Ash E. Donnall Thomas Lecture

The American Society of Hematology will honor Tomas Ganz, MD, PhD, of the University of California - Los Angeles with the 2014 E. Donnall Thomas Lecture for his groundbreaking research in iron homeostasis, including the discovery of the iron-regulatory hormone hepcidin and investigation of its roles in iron metabolism.

Comment?

Related Topix: UC Los Angeles, California, California Institute of Technology

WAFB-TV Baton Rouge

Scientists discover new way to make human platelets

Scientists report they have discovered a new way to make fully functional human platelets, which are the blood cells that form clots.

Comment?

Related Topix: Medicine, Brigham and Women's Hospital, Hospital Administration, Healthcare Industry

•••
•••
•••
•••
•••
•••
•••